Navigation Links
Alexza Announces Proposed Public Offering of Common Stock and Warrants
Date:2/16/2012

MOUNTAIN VIEW, Calif., Feb. 16, 2012 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA), today announced that it intends to offer shares of its common stock and warrants to purchase shares of its common stock in an underwritten public offering.  JMP Securities LLC is acting as the sole book-running manager in the offering.

The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Alexza plans to use the net proceeds from the sale of securities primarily for general corporate purposes, including regulatory, clinical trial, research and development, general and administrative and manufacturing expenses.

The offering is being made pursuant to a shelf registration statement on Form S-3 previously declared effective by the Securities and Exchange Commission, or the SEC, on May 20, 2010.  A preliminary prospectus supplement relating to the offering will be filed with the SEC.  When available, copies of the preliminary prospectus supplement relating to the offering and the accompanying base prospectus may be obtained by contacting JMP Securities LLC, 600 Montgomery Street, 10th Floor, San Francisco, California 94111, Attention: Prospectus Department, (415) 835-8985.  A copy of the preliminary prospectus supplement relating to the offering and the accompanying base prospectus may also be accessed on the SEC website, http://www.sec.gov.  Before you invest, you should read the preliminary prospectus supplement and the accompanying base prospectus in that registration statement and other documents Alexza has filed or will file with the SEC for more complete information about Alexza and the offering.

This press release does not constitute an offer to sell or the solicitation o
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... The Netherlands , April 1, 2015 /PRNewswire/ ... its ISO 13485 certificate for their 100% medical North ... medical device manufacturers throughout North America ... President of HealthLink Europe and HealthLink International: "We now ... in Europe and one in ...
(Date:4/1/2015)... LAVAL, Quebec , April 1, 2015 ... Salix "), a wholly owned subsidiary of Valeant Pharmaceuticals ... that it today provided a Notice of Fundamental Changes, ... Notice, Notice of Execution of Supplemental Indenture and Offer ... its 1.5% Convertible Senior Notes due 2019 (the " ...
(Date:4/1/2015)... April 1, 2015  New York College of Health ... Intellectual Properties portfolio with U.S. Patent #8,996,098 donated by ... patent represents a surgical instrument that allows surgeons to ... it were in the traditional format of a slide ... medical databases during surgery, thus providing the surgeon real ...
Breaking Medicine Technology:Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 2Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 3Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 4Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 5Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 6Salix Provides Notice of Fundamental Changes, Make-Whole Fundamental Changes and Merger Event Relating to Its 1.5% Convertible Senior Notes Due 2019 7Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 2Ground-Breaking Surgical Instrument Allows Surgeons to obtain Real Time Biopsies 3
... June 22 Hanger Orthopedic Group, Inc. (NYSE: HGR ... acquisition of Dynamic Orthotics and Prosthetics of Texas , Nebraska Orthotic ...  The companies operate 10 offices with annual revenues of $14.0 million ... "These companies ...
... 22 Xoft, makers of Electronic Brachytherapy systems ... integration of its Axxent® Electronic Brachytherapy System at the ... fully comprehensive breast center exclusively dedicated to the prevention, ... Lotus Breast Center is the first comprehensive breast center ...
Cached Medicine Technology:Hanger Orthopedic Group, Inc. Announces Three Acquisitions With Annual Revenues of $14.0 Million 2Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform 2Pink Lotus Breast Center to Integrate Electronic Brachytherapy Cancer Treatment Platform 3
(Date:4/2/2015)... CA (PRWEB) April 02, 2015 Veale ... and now two digital billboards to its name, announces ... billboard in the Dixon/Sacramento area. Similar to the ... freeway in Rohnert Park, California, the addition means, in ... the much sought after tourist population traveling through ...
(Date:4/2/2015)... 2015 New York Dynamic Neuromuscular Rehabilitation ... time in New York City, a groundbreaking, conservative method ... stroke (or other types of neurological diseases that damage ... A stroke is considered a cerebrovascular accident (CVA) that ... tissue resulting in damage to the nerve cells. Damage ...
(Date:4/1/2015)... Alcohol Awareness Month , The National Council ... sponsoring Alcohol Awareness Month every April since 1987. ... understating of alcohol-related issues. During the month of ... and alcoholism. , For the Health of It: Early ... for Alcohol Awareness Month. During April, focus is ...
(Date:4/1/2015)... April 01, 2015 NTOCC today launches ... of care tools that seek to improve care transitions ... program, NTOCC hopes to bring light to tools or ... of care across the healthcare industry through the promotion ... advance collaborative patient-care. Following that vision, the Knowledge & ...
(Date:4/1/2015)... 2015 New Jersey Governor First ... First Spouses from across the country in sponsoring ... 2015, World Down Syndrome Day(WDSD), to increase awareness ... area of Down syndrome cognition research. , In ... Alaska, American Samoa, Arizona, California, Colorado, Delaware, Florida, ...
Breaking Medicine News(10 mins):Health News:Veale Outdoor Advertising State of the Art Digital Billboards Reach 12 Million in SF Bay Area 2Health News:Virtual Environment Treatment Available for the First Time in NYC for Patients with Stroke 2Health News:Narconon Arrowhead Releases Guide to Handling Alcoholism in the Family for Alcohol Awareness Month 2Health News:Narconon Arrowhead Releases Guide to Handling Alcoholism in the Family for Alcohol Awareness Month 3Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 2Health News:National Transitions of Care Coalition Launches Knowledge & Resource Center 3Health News:Governor First Spouses Join with New Jersey First Lady Mary Pat Christie to Support Advances in Biomedical Research to Treat Down Syndrome Cognitive Impairment 2
... University of North Carolina in Chapel Hill that was published ... suggests that two genes - C282Y and H63D, which are ... to an increased risk of developing colon cancer. For the ... out// of which, more than 400 already had colon cancer, ...
... at Trinity College, Dublin, Ireland, have found from a ... arterial stiffness after smoking even one cigarette in both ... effects of smoking on large artery properties in 185 ... years. 116 non-smokers// were compared with 41 chronic smokers ...
... Patients with damaged discs have traditionally been treated by removing ... to fuse two bones together. Now, an artificial disc which ... phase of trials. The phase one study that was recently ... first phase of trials patients// were randomized, with one having ...
... banned in 1962, is being reassessed to find out if ... forms of cancer and leprosy. The drug which is unlicensed ... a cure for morning// sickness. However, it was banned after ... ,The European Agency for the Evaluation of Medicinal Products (EMEA) ...
... that were known until now were chickenpox, ear infections, ... found that stroke is also among one of the ... A National Hospital's database analysis by Dr. Donna Ferriero, ... that four in 1000 newborns had a stroke. ...
... survey across England showed that many do not eat ... other serious diseases. The survey included nearly// 15,600 adults ... revealed by the study. ,The survey indicated that ... household income. Almost 40% of women in the highest ...
Cached Medicine News:Health News:Artificial discs available as replacements for damaged discs 2Health News:Stroke also in list of common childhood ailments 2
... Alert Detection Reagents provide molecular labs a ... assays. By using our MGB technology, combined ... is now able to provide molecular labs ... sequences of specific organisms or genetic mutations ...
... present with fever, sore throat, ... symptoms common with a viral ... able to distinguish these from ... is the one-step antibody test ...
... hCG urine/serum combo test that you can ... and faster results at the point-of-care ... 20 hCG is a rapid test for ... immunoassay technology to selectively detect elevated levels ...
AUTION ELEVEN is the eleventh model of AUTION series which is ideal for use in small-to-medium-sized hospitals and clinics with its smart design and features....
Medicine Products: